The Therapeutic Goods Administration in Australia has proposed revisions to its premarket review process for medical devices, including subjecting surgically invasive and implantable systems designed for long-term use to the agency's mandatory application audit and easing its lower-risk device rules. The proposal is up for comment through March 15.

Related Summaries